|
Market Closed -
Other stock markets
|
After hours 23:59:59 | |||
| 160.50 EUR | -0.74% |
|
161.90 | +0.87% |
| 08-04 | Marengo Therapeutics, Inc. and Ipsen S.A. Nominate First Drug Candidate Under Strategic Tristar Collaboration | CI |
| 08-03 | Jefferies Downgrades Ipsen to Underperform, Boosts PT | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1,062B | |||||
| 619B | - | - | - | ||
| 431B | |||||
| 358B | |||||
| 293B |
- Stock Market
- Stocks
- IPN Stock
- 0MH6 Stock
- Charts Ipsen
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
